Note: This is not an exhaustive list.
1. Gilead to acquire biotech company for $405M
Foster City, Calif.-based pharmaceutical company Gilead plans to purchase MiroBio, an Oxford, England-based biotech business, for $405 million in cash.
2. Amgen to acquire ChemoCentryx for $3.7B
Amgen, a Thousand Oaks, Calif.-based pharmaceutical company, is set to buy autoimmune drugmaker ChemoCentryx for $3.7 billion in cash.
3. Pfizer to acquire Global Blood Therapeutics for $5.4B
Vaccine-maker Pfizer-BioNTech will acquire Global Blood Therapeutics, which specializes in blood disorder treatments, for $5.4 billion. No final acquisition date has been shared.
4. Shields Health Solutions partners with Billings Clinic
Shields, a Stoughton, Mass.-based specialty pharmacy company, lengthened its 5-yearslong partnership with a Montana clinic.
5. Boston biopharma company’s acquisition completed
Biopharmaceutical company Radius Health, based in Boston, was fully acquired from two investment firms.
6. Aerie Pharmaceuticals to be sold for $770M
Switzerland-based eye care company Alcon plans to buy Aerie Pharmaceuticals, a Durham, N.C.-based business that focuses on eye treatments, for $770 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.